The Ledger

UNH

UnitedHealth Group Inc.Health Caresp500

Last close $392.38May 11, 2026

Day +2.06%

Everything we've seen

·May 12, 4:04 PMstreamnews
Optum Rx Introduces Industry’s First Transparent Pharmacy Care Model
May 11, 2026--Today, Optum Rx announced a new pharmacy care model that fundamentally changes how pharmacy benefits are priced and delivered — replacing traditional approaches tied to drug prices set by manufacturers or prescription volume with a transparent, fee‑based structure offered to every Optum Rx PBM customer. The model is designed to fully align incentives with patients and plan sponsors, bringing greater clarity, predictability and affordability to pharmacy care — supported by digital c
·May 12, 4:04 PMstreamnews
Top Research Reports for UnitedHealth, Merck & Qualcomm
UnitedHealth, Merck and QUALCOMM lead Zacks' top research picks as analysts highlight growth drivers, earnings trends and key risks.
·May 12, 4:04 PMstreamnews
Optum Rx Pricing Shift Puts New Focus On UnitedHealth Group Valuation
Optum Rx, part of UnitedHealth Group, has rolled out a new fee-based pharmacy benefit management model that removes traditional volume-linked drug pricing. The model is paired with digital tools that show prescription level cost estimates to payers and patients. This change is intended to increase pricing clarity, align incentives across the drug supply chain, and influence how pharmacy benefits are structured. For investors watching NYSE:UNH, this move comes with the stock at a share price...
·May 12, 4:04 PMstreamnews
AI super rally has retail investors acting the most aggressive since trading frenzy during Covid
Retail traders are buying calls in Cboe's "Mag 10" stocks – the big seven plus AMD, Palantir and Broadcom – at the heaviest 10-day clip since 2021, according to a report from the exchange.
·May 12, 4:04 PMstreamnews
[Latest] Global Clinical Informatics Market Size/Share Worth USD 962.41 Billion by 2035 at a 13.36% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Clinical Informatics Market size & share revenue was valued at approximately USD 274.64 Billion in 2025 and is expected to reach USD 311.33 Billion in 2026 and is expected to reach around USD 962.41 Billion by 2035, at a CAGR of 13.36% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are Koninklijke Philips
·May 12, 4:04 PMstreamnews
The Zacks Analyst Blog UnitedHealth, Merck & Co., Qualcomm, EVI and Optex
UNH, MRK and QCOM drew focus as analysts highlighted growth drivers, pipeline strength and expanding AI and automotive opportunities.
·May 12, 4:04 PMstreamnews
Optum Rx shifts to fee-based PBM model in bid to boost transparency
Clients of the drug middleman can pay monthly fees per member that aren’t linked to manufacturers’ list prices or prescription volume.
·May 12, 4:04 PMstreamnews
Will UnitedHealth's New Optum Rx Model Boost PBM Pricing Transparency?
UNH's Optum Rx unveils a transparent, fee-based PBM model, ditching spread pricing and adding real-time cost tools as regulators push for lower drug pricing.
·May 12, 4:02 PMstreamnews
Optum Rx Introduces Industry’s First Transparent Pharmacy Care Model
May 11, 2026--Today, Optum Rx announced a new pharmacy care model that fundamentally changes how pharmacy benefits are priced and delivered — replacing traditional approaches tied to drug prices set by manufacturers or prescription volume with a transparent, fee‑based structure offered to every Optum Rx PBM customer. The model is designed to fully align incentives with patients and plan sponsors, bringing greater clarity, predictability and affordability to pharmacy care — supported by digital c
·May 12, 4:02 PMstreamnews
Top Research Reports for UnitedHealth, Merck & Qualcomm
UnitedHealth, Merck and QUALCOMM lead Zacks' top research picks as analysts highlight growth drivers, earnings trends and key risks.
·May 12, 4:02 PMstreamnews
Optum Rx Pricing Shift Puts New Focus On UnitedHealth Group Valuation
Optum Rx, part of UnitedHealth Group, has rolled out a new fee-based pharmacy benefit management model that removes traditional volume-linked drug pricing. The model is paired with digital tools that show prescription level cost estimates to payers and patients. This change is intended to increase pricing clarity, align incentives across the drug supply chain, and influence how pharmacy benefits are structured. For investors watching NYSE:UNH, this move comes with the stock at a share price...
·May 12, 4:02 PMstreamnews
AI super rally has retail investors acting the most aggressive since trading frenzy during Covid
Retail traders are buying calls in Cboe's "Mag 10" stocks – the big seven plus AMD, Palantir and Broadcom – at the heaviest 10-day clip since 2021, according to a report from the exchange.
·May 12, 4:02 PMstreamnews
[Latest] Global Clinical Informatics Market Size/Share Worth USD 962.41 Billion by 2035 at a 13.36% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Clinical Informatics Market size & share revenue was valued at approximately USD 274.64 Billion in 2025 and is expected to reach USD 311.33 Billion in 2026 and is expected to reach around USD 962.41 Billion by 2035, at a CAGR of 13.36% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are Koninklijke Philips
·May 12, 4:02 PMstreamnews
The Zacks Analyst Blog UnitedHealth, Merck & Co., Qualcomm, EVI and Optex
UNH, MRK and QCOM drew focus as analysts highlighted growth drivers, pipeline strength and expanding AI and automotive opportunities.
·May 12, 4:02 PMstreamnews
Optum Rx shifts to fee-based PBM model in bid to boost transparency
Clients of the drug middleman can pay monthly fees per member that aren’t linked to manufacturers’ list prices or prescription volume.
·May 12, 4:02 PMstreamnews
Will UnitedHealth's New Optum Rx Model Boost PBM Pricing Transparency?
UNH's Optum Rx unveils a transparent, fee-based PBM model, ditching spread pricing and adding real-time cost tools as regulators push for lower drug pricing.
·May 12, 4:01 PMstreamnews
Optum Rx Introduces Industry’s First Transparent Pharmacy Care Model
May 11, 2026--Today, Optum Rx announced a new pharmacy care model that fundamentally changes how pharmacy benefits are priced and delivered — replacing traditional approaches tied to drug prices set by manufacturers or prescription volume with a transparent, fee‑based structure offered to every Optum Rx PBM customer. The model is designed to fully align incentives with patients and plan sponsors, bringing greater clarity, predictability and affordability to pharmacy care — supported by digital c
·May 12, 4:01 PMstreamnews
Top Research Reports for UnitedHealth, Merck & Qualcomm
UnitedHealth, Merck and QUALCOMM lead Zacks' top research picks as analysts highlight growth drivers, earnings trends and key risks.
·May 12, 4:01 PMstreamnews
Optum Rx Pricing Shift Puts New Focus On UnitedHealth Group Valuation
Optum Rx, part of UnitedHealth Group, has rolled out a new fee-based pharmacy benefit management model that removes traditional volume-linked drug pricing. The model is paired with digital tools that show prescription level cost estimates to payers and patients. This change is intended to increase pricing clarity, align incentives across the drug supply chain, and influence how pharmacy benefits are structured. For investors watching NYSE:UNH, this move comes with the stock at a share price...
·May 12, 4:01 PMstreamnews
AI super rally has retail investors acting the most aggressive since trading frenzy during Covid
Retail traders are buying calls in Cboe's "Mag 10" stocks – the big seven plus AMD, Palantir and Broadcom – at the heaviest 10-day clip since 2021, according to a report from the exchange.
·May 12, 4:01 PMstreamnews
[Latest] Global Clinical Informatics Market Size/Share Worth USD 962.41 Billion by 2035 at a 13.36% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Clinical Informatics Market size & share revenue was valued at approximately USD 274.64 Billion in 2025 and is expected to reach USD 311.33 Billion in 2026 and is expected to reach around USD 962.41 Billion by 2035, at a CAGR of 13.36% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are Koninklijke Philips
·May 12, 4:01 PMstreamnews
The Zacks Analyst Blog UnitedHealth, Merck & Co., Qualcomm, EVI and Optex
UNH, MRK and QCOM drew focus as analysts highlighted growth drivers, pipeline strength and expanding AI and automotive opportunities.
·May 12, 4:01 PMstreamnews
Optum Rx shifts to fee-based PBM model in bid to boost transparency
Clients of the drug middleman can pay monthly fees per member that aren’t linked to manufacturers’ list prices or prescription volume.
·May 12, 4:01 PMstreamnews
Will UnitedHealth's New Optum Rx Model Boost PBM Pricing Transparency?
UNH's Optum Rx unveils a transparent, fee-based PBM model, ditching spread pricing and adding real-time cost tools as regulators push for lower drug pricing.
·May 12, 3:58 PMstreamnews
Optum Rx Introduces Industry’s First Transparent Pharmacy Care Model
May 11, 2026--Today, Optum Rx announced a new pharmacy care model that fundamentally changes how pharmacy benefits are priced and delivered — replacing traditional approaches tied to drug prices set by manufacturers or prescription volume with a transparent, fee‑based structure offered to every Optum Rx PBM customer. The model is designed to fully align incentives with patients and plan sponsors, bringing greater clarity, predictability and affordability to pharmacy care — supported by digital c
·May 12, 3:58 PMstreamnews
Top Research Reports for UnitedHealth, Merck & Qualcomm
UnitedHealth, Merck and QUALCOMM lead Zacks' top research picks as analysts highlight growth drivers, earnings trends and key risks.
·May 12, 3:58 PMstreamnews
Optum Rx Pricing Shift Puts New Focus On UnitedHealth Group Valuation
Optum Rx, part of UnitedHealth Group, has rolled out a new fee-based pharmacy benefit management model that removes traditional volume-linked drug pricing. The model is paired with digital tools that show prescription level cost estimates to payers and patients. This change is intended to increase pricing clarity, align incentives across the drug supply chain, and influence how pharmacy benefits are structured. For investors watching NYSE:UNH, this move comes with the stock at a share price...
·May 12, 3:58 PMstreamnews
AI super rally has retail investors acting the most aggressive since trading frenzy during Covid
Retail traders are buying calls in Cboe's "Mag 10" stocks – the big seven plus AMD, Palantir and Broadcom – at the heaviest 10-day clip since 2021, according to a report from the exchange.
·May 12, 3:58 PMstreamnews
[Latest] Global Clinical Informatics Market Size/Share Worth USD 962.41 Billion by 2035 at a 13.36% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Clinical Informatics Market size & share revenue was valued at approximately USD 274.64 Billion in 2025 and is expected to reach USD 311.33 Billion in 2026 and is expected to reach around USD 962.41 Billion by 2035, at a CAGR of 13.36% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are Koninklijke Philips
·May 12, 3:58 PMstreamnews
The Zacks Analyst Blog UnitedHealth, Merck & Co., Qualcomm, EVI and Optex
UNH, MRK and QCOM drew focus as analysts highlighted growth drivers, pipeline strength and expanding AI and automotive opportunities.
·May 12, 3:58 PMstreamnews
Optum Rx shifts to fee-based PBM model in bid to boost transparency
Clients of the drug middleman can pay monthly fees per member that aren’t linked to manufacturers’ list prices or prescription volume.
·May 12, 3:58 PMstreamnews
Will UnitedHealth's New Optum Rx Model Boost PBM Pricing Transparency?
UNH's Optum Rx unveils a transparent, fee-based PBM model, ditching spread pricing and adding real-time cost tools as regulators push for lower drug pricing.
·May 12, 3:56 PMstreamnews
Optum Rx Introduces Industry’s First Transparent Pharmacy Care Model
May 11, 2026--Today, Optum Rx announced a new pharmacy care model that fundamentally changes how pharmacy benefits are priced and delivered — replacing traditional approaches tied to drug prices set by manufacturers or prescription volume with a transparent, fee‑based structure offered to every Optum Rx PBM customer. The model is designed to fully align incentives with patients and plan sponsors, bringing greater clarity, predictability and affordability to pharmacy care — supported by digital c
·May 12, 3:56 PMstreamnews
Top Research Reports for UnitedHealth, Merck & Qualcomm
UnitedHealth, Merck and QUALCOMM lead Zacks' top research picks as analysts highlight growth drivers, earnings trends and key risks.
·May 12, 3:56 PMstreamnews
Optum Rx Pricing Shift Puts New Focus On UnitedHealth Group Valuation
Optum Rx, part of UnitedHealth Group, has rolled out a new fee-based pharmacy benefit management model that removes traditional volume-linked drug pricing. The model is paired with digital tools that show prescription level cost estimates to payers and patients. This change is intended to increase pricing clarity, align incentives across the drug supply chain, and influence how pharmacy benefits are structured. For investors watching NYSE:UNH, this move comes with the stock at a share price...
·May 12, 3:56 PMstreamnews
AI super rally has retail investors acting the most aggressive since trading frenzy during Covid
Retail traders are buying calls in Cboe's "Mag 10" stocks – the big seven plus AMD, Palantir and Broadcom – at the heaviest 10-day clip since 2021, according to a report from the exchange.
·May 12, 3:56 PMstreamnews
[Latest] Global Clinical Informatics Market Size/Share Worth USD 962.41 Billion by 2035 at a 13.36% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Clinical Informatics Market size & share revenue was valued at approximately USD 274.64 Billion in 2025 and is expected to reach USD 311.33 Billion in 2026 and is expected to reach around USD 962.41 Billion by 2035, at a CAGR of 13.36% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are Koninklijke Philips
·May 12, 3:56 PMstreamnews
The Zacks Analyst Blog UnitedHealth, Merck & Co., Qualcomm, EVI and Optex
UNH, MRK and QCOM drew focus as analysts highlighted growth drivers, pipeline strength and expanding AI and automotive opportunities.
·May 12, 3:56 PMstreamnews
Optum Rx shifts to fee-based PBM model in bid to boost transparency
Clients of the drug middleman can pay monthly fees per member that aren’t linked to manufacturers’ list prices or prescription volume.
·May 12, 3:56 PMstreamnews
Will UnitedHealth's New Optum Rx Model Boost PBM Pricing Transparency?
UNH's Optum Rx unveils a transparent, fee-based PBM model, ditching spread pricing and adding real-time cost tools as regulators push for lower drug pricing.
·May 12, 3:54 PMstreamnews
AI super rally has retail investors acting the most aggressive since trading frenzy during Covid
Retail traders are buying calls in Cboe's "Mag 10" stocks – the big seven plus AMD, Palantir and Broadcom – at the heaviest 10-day clip since 2021, according to a report from the exchange.
·May 12, 3:54 PMstreamnews
[Latest] Global Clinical Informatics Market Size/Share Worth USD 962.41 Billion by 2035 at a 13.36% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Clinical Informatics Market size & share revenue was valued at approximately USD 274.64 Billion in 2025 and is expected to reach USD 311.33 Billion in 2026 and is expected to reach around USD 962.41 Billion by 2035, at a CAGR of 13.36% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are Koninklijke Philips
·May 12, 3:54 PMstreamnews
The Zacks Analyst Blog UnitedHealth, Merck & Co., Qualcomm, EVI and Optex
UNH, MRK and QCOM drew focus as analysts highlighted growth drivers, pipeline strength and expanding AI and automotive opportunities.
·May 12, 3:54 PMstreamnews
Optum Rx shifts to fee-based PBM model in bid to boost transparency
Clients of the drug middleman can pay monthly fees per member that aren’t linked to manufacturers’ list prices or prescription volume.
·May 12, 3:54 PMstreamnews
Will UnitedHealth's New Optum Rx Model Boost PBM Pricing Transparency?
UNH's Optum Rx unveils a transparent, fee-based PBM model, ditching spread pricing and adding real-time cost tools as regulators push for lower drug pricing.
!May 12, 3:31 PMsignal
Agent VII — Day Trader — analyze_failed
?May 12, 3:15 PMdecisionconsidered
Agent VII — Day Trader — decide: skip
UNH is up 2.75% with no recent headlines to explain the catalyst, making it difficult to assess whether this is a sustained move or a thin-volume spike. With only 30 minutes remaining until the forced close, there is limited time for meaningful additional upside even if the move is legitimate. The macro context (elevated inflation expectations) is not directly relevant to UNH, providing no additional tailwind to support continuation.
!May 12, 3:15 PMsignalseverity 0.03
Agent VII — Day Trader — day_trade_skipped
UNH is up 2.75% with no recent headlines to explain the catalyst, making it difficult to assess whether this is a sustained move or a thin-volume spike. With only 30 minutes remaining until the forced close, there is limited time for meaningful additional upside even if the move is legitimate. The macro context (elevated inflation expectations) is not directly relevant to UNH, providing no additional tailwind to support continuation.
?May 12, 3:01 PMdecisionconsidered
Agent VII — Day Trader — decide: skip
UNH is up 2.44% with no recent headlines to explain the catalyst, making it difficult to assess whether this move has fundamental support or is simply mean-reverting noise. The macro context (elevated inflation expectations via T5YIE) is not directly relevant to a managed care/health insurance name like UNH. With only 45 minutes remaining until the forced close, there is limited time for the move to extend meaningfully, and without a clear catalyst, the risk of intraday reversal or fade into the close is elevated.
!May 12, 3:01 PMsignalseverity 0.02
Agent VII — Day Trader — day_trade_skipped
UNH is up 2.44% with no recent headlines to explain the catalyst, making it difficult to assess whether this move has fundamental support or is simply mean-reverting noise. The macro context (elevated inflation expectations via T5YIE) is not directly relevant to a managed care/health insurance name like UNH. With only 45 minutes remaining until the forced close, there is limited time for the move to extend meaningfully, and without a clear catalyst, the risk of intraday reversal or fade into the close is elevated.
?May 12, 2:45 PMdecisionconsidered
Agent VII — Day Trader — decide: skip
UNH has moved up 3.12% with no identifiable catalyst from recent headlines, suggesting this may be a gap or thin-volume spike rather than a news-driven continuation move. The macro context (elevated inflation expectations via T5YIE) is not directly supportive of healthcare sector upside. With only 60 minutes remaining until the forced close, there is limited runway even if momentum were present, and mean-reversion risk in a no-news environment is elevated.
!May 12, 2:45 PMsignalseverity 0.03
Agent VII — Day Trader — day_trade_skipped
UNH has moved up 3.12% with no identifiable catalyst from recent headlines, suggesting this may be a gap or thin-volume spike rather than a news-driven continuation move. The macro context (elevated inflation expectations via T5YIE) is not directly supportive of healthcare sector upside. With only 60 minutes remaining until the forced close, there is limited runway even if momentum were present, and mean-reversion risk in a no-news environment is elevated.
?May 12, 2:31 PMdecisionconsidered
Agent VII — Day Trader — decide: skip
UNH has moved up 3.01% today but there are no supporting headlines or catalysts visible to explain the move, making it difficult to assess whether this is a fundamental re-rating or a technical/flow-driven spike. The macro context (elevated inflation expectations via T5YIE) is not directly supportive of managed care/healthcare insurers. With 74 minutes remaining, some mean reversion or consolidation is plausible absent a clear catalyst, so a high-confidence continuation call is not warranted.
!May 12, 2:31 PMsignalseverity 0.03
Agent VII — Day Trader — day_trade_skipped
UNH has moved up 3.01% today but there are no supporting headlines or catalysts visible to explain the move, making it difficult to assess whether this is a fundamental re-rating or a technical/flow-driven spike. The macro context (elevated inflation expectations via T5YIE) is not directly supportive of managed care/healthcare insurers. With 74 minutes remaining, some mean reversion or consolidation is plausible absent a clear catalyst, so a high-confidence continuation call is not warranted.
?May 12, 2:15 PMdecisionconsidered
Agent VII — Day Trader — decide: skip
UNH is up 2.15% with no recent headlines to explain the catalyst, making it difficult to assess whether this move is driven by substantive news or is a thin-volume drift. The macro context (elevated 5-year inflation expectations) is not directly relevant to managed healthcare and provides no sector tailwind. With 90 minutes remaining, there is time for continuation but without a clear catalyst, mean reversion into the close is equally plausible, especially given UNH's recent broader volatility.
!May 12, 2:15 PMsignalseverity 0.02
Agent VII — Day Trader — day_trade_skipped
UNH is up 2.15% with no recent headlines to explain the catalyst, making it difficult to assess whether this move is driven by substantive news or is a thin-volume drift. The macro context (elevated 5-year inflation expectations) is not directly relevant to managed healthcare and provides no sector tailwind. With 90 minutes remaining, there is time for continuation but without a clear catalyst, mean reversion into the close is equally plausible, especially given UNH's recent broader volatility.
!May 12, 2:09 PMsignal
Agent VI — Options Momentum — insufficient_capital
?May 12, 1:30 PMdecisionconsidered
Agent VII — Day Trader — decide: skip
UNH is up 2.61% with no identifiable news catalyst in the headlines, suggesting the move may be a gap or algorithmic/sector rotation trade rather than a fundamentally driven continuation. The macro context (elevated 5-year inflation expectations) is not a direct tailwind for managed healthcare names and provides no supporting narrative. With 135 minutes remaining there is time for continuation, but without a clear catalyst and given UNH's recent volatility history in the healthcare sector, the risk of mean reversion or fading into the close is material.
!May 12, 1:30 PMsignalseverity 0.03
Agent VII — Day Trader — day_trade_skipped
UNH is up 2.61% with no identifiable news catalyst in the headlines, suggesting the move may be a gap or algorithmic/sector rotation trade rather than a fundamentally driven continuation. The macro context (elevated 5-year inflation expectations) is not a direct tailwind for managed healthcare names and provides no supporting narrative. With 135 minutes remaining there is time for continuation, but without a clear catalyst and given UNH's recent volatility history in the healthcare sector, the risk of mean reversion or fading into the close is material.
?May 12, 1:15 PMdecisionconsidered
Agent VII — Day Trader — decide: skip
UNH is up 2.25% but there are no UNH-specific headlines or catalysts visible in the evidence to explain or support continuation of this move — the only headline references AMD and unrelated growth stocks. The macro context (elevated 5Y inflation expectations) is mildly negative for healthcare/managed care names as it pressures discount rates and cost assumptions, not a tailwind. With 150 minutes remaining there is time for a move, but without a clear fundamental catalyst driving this specific ticker, the rally looks more like a gap or sector rotation bounce that may fade rather than accelerate into the close.
!May 12, 1:15 PMsignalseverity 0.02
Agent VII — Day Trader — day_trade_skipped
UNH is up 2.25% but there are no UNH-specific headlines or catalysts visible in the evidence to explain or support continuation of this move — the only headline references AMD and unrelated growth stocks. The macro context (elevated 5Y inflation expectations) is mildly negative for healthcare/managed care names as it pressures discount rates and cost assumptions, not a tailwind. With 150 minutes remaining there is time for a move, but without a clear fundamental catalyst driving this specific ticker, the rally looks more like a gap or sector rotation bounce that may fade rather than accelerate into the close.
!May 12, 12:06 PMsignal
Agent VI — Options Momentum — insufficient_capital
!May 12, 12:04 PMsignal
Agent VI — Options Momentum — insufficient_capital
❖May 11, 1:20 PMnewsvia finnhub
Advanced Micro Devices and Other Growth Stocks Are Flying High. History Says Hold on to Them.
If it feels like growth stocks can’t continue their outperformance much longer, ignore that feeling. The Vanguard S&P 500 Growth Index Fund Exchange-Traded Fund, home to companies with high sales growth including Nvidia Advanced Micro Devices Microsoft and Eli Lilly is up 13% in the past month. A couple of factors have driven the performance of the growth stocks.
❖May 11, 12:31 PMnewsvia finnhub
Optum Rx Introduces Industry’s First Transparent Pharmacy Care Model
Market-leading approach to client and consumer transparency further aligns incentives across patients and plan sponsors, offering consumers new affordability tools...
❖May 11, 10:49 AMnewsvia finnhub
Nvidia Tops Buy Point. 5 Dow Stocks Near Entries Share This Flaw
Nvidia topped a buy point on Monday after Boeing provided an entry on Friday, among five Dow stocks to watch near buy points this week. Nvidia stock and its peers have rallied in a soaring stock market, with earnings out of the way for some of these names but not for others. Walmart, Goldman Sachs and UnitedHealth also make the cut.
❖May 11, 4:34 AMnewsvia finnhub
Teva's CNS Portfolio Is Growing, But Valuation Is Stretched
Teva trades at the non-GAAP P/E ratio of 14.93x, which is 65.9% higher than Sanofi's. Find out why TEVA stock is a Sell.
❖May 11, 4:31 AMnewsvia finnhub
Dr. Scott Gottlieb: Could see more hantavirus case, but don't think it will get out of control
Former FDA Commissioner Dr. Scott Gottlieb joins 'Squawk Box' to discuss the state of the hantavirus outbreak, risk of a wider outbreak, fate of FDA Commissioner Marty Makary, FDA's new flavored vape policy, and more.
❖May 9, 8:00 AMnewsvia finnhub
Nvidia, Boeing Lead 5 Dow Stocks Near Buy Points. They Share This Flaw.
Nvidia and Boeing lead five Dow stocks to watch near buy points this week. Nvidia stock and its peers have rallied in a soaring stock market, with earnings out of the way for some of these names but not for others. Walmart, Goldman Sachs and UnitedHealth also make the cut.
❖May 9, 1:18 AMnewsvia finnhub
UnitedHealth Group (UNH) Valuation Check After Earnings Beat Guidance Lift And Prior Authorization Cuts
UnitedHealth Group (UNH) has been in focus after first quarter 2026 earnings, a higher full year earnings outlook, and plans to cut prior authorization requirements, while analysts highlighted the stock following these updates. See our latest analysis for UnitedHealth Group. The stock has reacted strongly to the first quarter earnings update and guidance lift, with a 30 day share price return of 20.15% and 90 day share price return of 33.65%. However, the 1 year total shareholder return is...
❖May 7, 7:41 PMnewsvia finnhub
UnitedHealth to Eliminate Prior Authorization for 30% of Healthcare Services
UnitedHealth Group Incorporated (NYSE:UNH) is included among the 10 Best Value Stocks to Buy in 2026 According to Warren Buffett. On May 5, UnitedHealth Group Incorporated (NYSE:UNH) announced that it is removing authorization requirements for 30% of healthcare services that previously needed insurer approval. The company said the move builds on several recent commitments aimed […]
❖May 7, 6:41 PMnewsvia finnhub
Bullish Quarterly Results: 3 Companies Raising Guidance
Guidance upgrades are generally among the most bullish announcements a company can make, signaling that the outlook is even better than previously expected.
❖May 7, 11:17 AMnewsvia finnhub
Marriott Bonvoy Business card review: Earn up to 5 free nights, worth up to 250,000 points
The Marriott Bonvoy Business card is worth keeping for its annual free night and elite status perks.
❖May 7, 10:19 AMnewsvia finnhub
How CVS Health's Transformation Is Facing A Hard Valuation Floor
The most significant insight currently obscured by CVS Health's (CVS) headline revenue growth is a high-stakes transition: the company is attempting to use a temporary surge in insurance profitability to outrun the structural margin pressures facing its pharmacy benefit management (PBM) business.
❖May 7, 4:00 AMnewsvia finnhub
UnitedHealth: Watch The Recovery In Action
UnitedHealth Group is executing a robust turnaround, with Q1 2026 revenue up 2% to $111.7 billion. Read why UNH stock is a Buy.
❖May 6, 11:46 AMnewsvia finnhub
THC Beats Q1 Earnings Estimates on Strong Ambulatory Growth, Ups '26 EPS View
Tenet Healthcare tops Q1 EPS estimates as admissions and ambulatory growth drive gains, but payer mix pressures and rising costs weigh on margins.
❖May 6, 10:09 AMnewsvia finnhub
CVS Stock Breaks Out On Earnings Due To ACA Exit, Premium Hikes
CVS stock is breaking out on Wednesday morning after it posted better-than-expected first-quarter results and raised its full-year outlook. Of CVS Health's three big segments, its health benefits segment saw operating income surge by $1.05 billion, or 53%.
❖May 6, 7:48 AMnewsvia finnhub
5 Goldman Sachs Top Picks for May Are Safe, Pay Dividends With Double-Digit Upside
Founded in 1869, Goldman Sachs is the world’s second-largest investment bank by revenue and is ranked 82nd on the Fortune 500 list of the largest U.S. corporations by total revenue. The Wall Street white-glove firm offers financing, advisory services, risk distribution, and hedging for the firm’s institutional and corporate clients. In addition, they produce some ... 5 Goldman Sachs Top Picks for May Are Safe, Pay Dividends With Double-Digit Upside
❖May 6, 7:02 AMnewsvia finnhub
CVS Health Stock Jumps After Earnings. What’s Encouraging Wall Street.
CVS Health’s Aetna was the third-largest provider of Medicare Advantage plans in 2025, behind UnitedHealth Group and Humana.
❖May 6, 3:38 AMnewsvia finnhub
Live Nation Entertainment, TransDigm Group, Interactive Brokers And A Health Care Stock: CNBC's 'Final Trades'
Live Nation and TransDigm each reported positive first-quarter earnings, while Interactive Brokers Group hit an all-time high.
❖May 5, 9:08 PMnewsvia finnhub
UnitedHealth Prior Authorization Shift And What It Could Mean For UNH Stock
UnitedHealthcare, part of UnitedHealth Group (NYSE:UNH), plans to remove prior authorization requirements for a large share of healthcare services starting in 2026. The change is intended to cut administrative complexity, while aiming to improve access and affordability for patients and providers. This policy update affects core insurance operations and could influence how hospitals, physicians and patients interact with NYSE:UNH plans. For a company of UnitedHealth Group's scale in US...
❖May 5, 6:42 PMnewsvia finnhub
Why UnitedHealth Group Stock Came Roaring Back In April
The insurer and healthcare giant is getting back to a solid profit footing.
❖May 5, 5:15 PMnewsvia finnhub
CVS Has Two Hurdles to Clear in Earnings. Medicare Advantage Just Might Be the Lower One.
CVS Health’s Aetna was the third-largest provider of Medicare Advantage plans in 2025, behind UnitedHealth Group and Humana.
❖May 5, 2:57 PMnewsvia finnhub
ENSG Tops Q1 EPS Estimates on Patient Growth, Raises '26 Outlook
Ensign Group tops Q1 EPS estimates as occupancy gains and acquisitions fuel growth, while higher costs and a slight revenue miss temper results.
❖May 5, 1:00 PMnewsvia finnhub
Highmark Health Appoints Heather Cianfrocco as Chief Operating Officer
Highmark Health announced today the appointment of Heather Cianfrocco to the role of chief operating officer for the organization, effective immediately. Cianfrocco joins Highmark Health from UnitedHealth Group where she held various leadership roles across the benefits and services businesses.
❖May 5, 12:31 PMnewsvia finnhub
Highmark Health names ex-UnitedHealth exec as COO
Heather Cianfrocco is joining the Pittsburgh-based healthcare company as its COO effective immediately.
❖May 5, 11:05 AMnewsvia finnhub
Apple, Amazon, TSMC Top List Of Earnings Triple Plays As Beat-And-Raise Stocks Surge
Apple, Amazon and TSMC are among the largest companies to deliver earnings "triple plays" this season.
❖May 5, 10:11 AMnewsvia finnhub
Goldman Sachs Names UnitedHealth (UNH) to Conviction List, Keeps $435 Price Target
UnitedHealth Group Incorporated (NYSE:UNH) is included among the 10 Best Blue Chip Stocks to Invest in According to Billionaires. On May 1, Goldman Sachs added UnitedHealth Group Incorporated (NYSE:UNH) to its U.S. Conviction List as part of its monthly update. The firm believes the company is nearing the bottom of its underwriting cycle for Medicare […]
❖May 5, 9:05 AMnewsvia finnhub
Final Trades: Live Nation, Transdigm, UnitedHealth and Interactive Brokers
The Investment Committee give you their top stocks to watch for the second half.
❖May 5, 8:40 AMnewsvia finnhub
Wall Street Lunch: Global Borrowing Costs Surge On Rising Oil, Renewed Inflation Concerns
Global borrowing costs continue to climb as elevated oil prices fuel expectations that central banks may need to tighten policy to contain renewed inflation pressures.
❖May 5, 6:00 AMnewsvia finnhub
UnitedHealthcare Cuts Prior Authorization Requirements by 30%
May 05, 2026--UnitedHealthcare is eliminating authorization requirements for 30% of healthcare services that previously required insurer approval.
❖May 5, 4:07 AMnewsvia finnhub
Iran tensions, Palantir earnings, Musk's SEC settlement and more in Morning Squawk
Here are five key things investors need to know to start the trading day.
❖May 5, 3:44 AMnewsvia finnhub
Airlines could be at a 'wild coyote moment' says analyst
Alexander Irving, Airlines Analyst at Bernstein discusses the potentially crisis in jet fuel supplies if the Iran War continues.
❖May 5, 3:00 AMnewsvia finnhub
Major health insurers show signs of recovery – but a key test looms
Insurers have incomplete data on medical costs in the first quarter due to a lag in claims processing, which sets up the second quarter as the real test.
❖May 5, 2:42 AMnewsvia finnhub
UnitedHealthcare removes prior approval requirements for 30% of healthcare services
UnitedHealth will eliminateprior approval requirements for 30% of healthcare services, itsinsurance unit said on Tuesday, further reducing delays andpaperwork for patients and doctors. ...
❖May 5, 2:08 AMnewsvia finnhub
Unitedhealthcare Is Eliminating Authorization Requirements For 30% Of Healthcare Services That Previously Required Insurer Approval
This initiative builds on a series of recent, industry-leading commitments the company has made to make healthcare simpler and more affordable, while raising the bar for transparency and accountability across the
❖May 4, 9:12 PMnewsvia finnhub
How Investors Are Reacting To UnitedHealth Group (UNH) Earnings Beat, Guidance Hike and Governance Challenge
In April 2026, UnitedHealth Group reported first-quarter 2026 results showing revenue of US$111.72 billion and net income of US$6.28 billion, while also facing a shareholder proposal from The Accountability Board to require an independent Board Chair, which the company’s proxy statement urged investors to vote against. This mix of steady financial performance and a governance challenge highlights how UnitedHealth’s board structure and oversight practices are coming under closer investor...
❖May 4, 12:52 PMnewsvia finnhub
Acadia Healthcare Q1 Earnings Beat Estimates on Rising Patient Days
ACHC Q1 tops estimates with 37 cents EPS and 7.6% revenue growth, driven by higher patient days and admissions despite shorter stays and rising costs.
❖May 4, 12:39 PMnewsvia finnhub
Select Medical Q1 Earnings Miss Estimates on Higher Expenses
SEM's Q1 EPS misses due to higher expenses and weaker patient days, even as revenues top estimates and rehab segment growth partly offsets pressure.
❖May 4, 9:40 AMnewsvia finnhub
TDOC Q1 Earnings Miss, Revenues Down Y/Y on BetterHelp Weakness
Teladoc Health posts a y/y narrower Q1 loss and beats revenue estimates as international growth and cost cuts offset BetterHelp weakness and subscription declines.
❖May 4, 8:54 AMnewsvia finnhub
Beat the Market Like Zacks: Vicor, NVIDIA, UnitedHealth in Focus
VICR, NVDA and UNH lead gains as Zacks-backed picks outperform the broader market across multiple portfolios.
❖May 4, 8:16 AMnewsvia finnhub
Here's How Much $100 Invested In UnitedHealth Group 15 Years Ago Would Be Worth Today
❖May 4, 7:43 AMnewsvia finnhub
How to buy a major Dow component, at a discount
UnitedHealth is one of the largest U.S. companies in one of the largest sectors that pays a respectable dividend. Mike Khouw still wouldn't buy the stock outright.
❖May 4, 7:42 AMnewsvia finnhub
This healthcare stock has turned a corner. Here's how to get long at a discount
Mike Khouw, strategist at YieldMaxETFs, explains why he favors an options strategy for this healthcare giant.
❖May 3, 11:13 PMnewsvia finnhub
Tracking AMG's Yacktman Asset Management Portfolio - Q1 2026 Update
Yacktman Asset Management's Q1 2026 13F portfolio rose to ~$7.5B, with 76 holdings and 11.5% cash, led by Canadian Natural Resources at 10.75%. View the full analysis here.
❖May 3, 12:36 AMnewsvia finnhub
1 Cash-Producing Stock Worth Investigating and 2 Facing Headwinds
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.
❖May 2, 8:09 AMnewsvia finnhub
Is It Time To Reassess UnitedHealth Group (UNH) After Its Sharp 30 Day Rally?
This article examines whether UnitedHealth Group at around US$368.78 may be attractively priced or simply fairly valued, and explains what the current share price could mean for you. The stock has returned 3.9% over the last 7 days and 34.6% over the last 30 days, while the 1 year return is a 5.2% decline and the 3 year return is a 20.9% decline, with a 9.6% year to date gain. Recent coverage has focused on UnitedHealth Group's role as a major US healthcare and insurance provider, including...
❖May 1, 11:49 PMnewsvia finnhub
Elon Musk's $4.8 Million Security Tab Reveals Rising Risks For Billionaire CEOs
Tesla increased security spending for CEO Elon Musk to $4.8 million in 2025, reflecting rising executive safety concerns.
❖May 1, 12:37 PMnewsvia finnhub
Goldman Sachs Adds UnitedHealth to Its Conviction List: Is the Managed Care Comeback Real?
Goldman Sachs (NYSE:GS) added UnitedHealth Group (NYSE:UNH) stock to its U.S. Conviction List, reiterating a Buy rating with a $435 price target. The firm argues UnitedHealth is nearing the bottom of its underwriting cycle in Medicare Advantage (MA), which represents 40% of its business. The Conviction List is reserved for Goldman’s highest-conviction Buy ideas. UnitedHealth ... Goldman Sachs Adds UnitedHealth to Its Conviction List: Is the Managed Care Comeback Real?
❖May 1, 12:29 PMnewsvia finnhub
UnitedHealth Stock Just Made Goldman’s Conviction List. It’s a ‘Shrink to Grow’ Story.
UnitedHealth Group’s comeback got a serious boost when it scored an earnings beat a couple of weeks ago. Now, it’s being added to Goldman Sachs’ U.S. Conviction List—Director’s Cut, an acclaimed rundown of Buy-rated stocks. Goldman likes the healthcare company’s plans to get smaller in Medicare Advantage, calling it a “shrink to grow” story.
❖May 1, 12:07 PMnewsvia finnhub
S&P 500's Best‑Kept Secret: Why Healthcare Could Be 2026's Breakout Winner
AI‑powered drug discovery, strong earnings upgrades, and rising institutional flows show why healthcare may shift from 2026 laggard to breakout S&P 500 growth story.
❖May 1, 11:32 AMnewsvia finnhub
SCHD: Go Back To Bed, Why You'll Sleep Well At Night
❖May 1, 10:27 AMnewsvia finnhub
UnitedHealth Pops 14.5% After Q1 Beat: Still a Buy or Too Late Now?
UNH surges 14.5% after a Q1 earnings beat and raised 2026 outlook, but membership declines, DOJ probes and valuation concerns could cap the rally.

← Back to dashboard